Evidence map›Paper›PMID 39452235›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Three Days of Oral Azithromycin Versus Five Days of Oral Clarithromycin in the Treatment of Campylobacter Enterocolitis in Children: A Prospective Study.

Hyun Mi Kang, Yoon Kyung Cho, Ye Ji Kim, Dae Chul Jeong, In Hyuk Yoo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hyun Mi KangDepartment of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Yoon Kyung ChoDepartment of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Ye Ji KimDepartment of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Dae Chul JeongDepartment of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
In Hyuk YooDepartment of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0003-1607-0890

Funding

Daewon Pharmaceutical Company 2002-1235-0010
6 · The paper itself

Abstract

objectiveThis study aimed to compare the efficacy and tolerability of azithromycin and clarithromycin in pediatric

methodsA prospective, randomized, controlled trial was conducted at a single center. Patients with confirmed

resultsA total of 29 pediatric patients were included, with 14 patients in the azithromycin group and 15 patients in the clarithromycin group. The median age of patients in the azithromycin group was 10.0 years (interquartile range [IQR]: 5.0-13.0), and in the clarithromycin group, the median age was 9.0 years (IQR: 7.0-13.0) (

conclusionsClarithromycin was found to be as effective as azithromycin in treating pediatric

Indexed as

azithromycinCampylobacter enterocolitisclarithromycinpediatric

Identifiers

PMID39452235
PMCPMC11504726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.